Article info

Download PDFPDF

Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study
  1. M Rudwaleit, Charité, Campus Benjamin Franklin Hospital, Medical Department I, Rheumatology, Hindenburgdamm 30, 12200 Berlin, Germany; martin.rudwaleit{at}charite.de
View Full Text

Citation

Rudwaleit M, Rødevand E, Holck P, et al
Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study

Publication history

  • Accepted July 13, 2008
  • First published July 28, 2008.
Online issue publication 
April 14, 2009

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.